2022
DOI: 10.3389/fimmu.2022.945504
|View full text |Cite
|
Sign up to set email alerts
|

SFRP4+IGFBP5hi NKT cells induced neural-like cell differentiation to contribute to adenomyosis pain

Abstract: BackgroundAdenomyosis is an estrogen-dependent gynecological disease. The pathogenesis of chronic pain, the main clinical symptom of adenomyosis, remains undefined. As a combination lymphocyte with both T-cell and natural killer (NK)–cell properties, NK T (NKT) cells play a role in immune defense against numerous diseases and modulate cell differentiation.MethodThis study analyzed the tissue-cell samples from adenomyosis with or without pain by single-cell sequencing.ResultWe found a specific population of sec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 49 publications
0
5
0
Order By: Relevance
“…PCSK9 [48], CNTN4 [49], SEMA3A [50], SFRP4 [51], MFAP5 [52], BMP6 [53], CDH6 [54], PIEZO2 [55] and PKP2 [56] are a diagnostic markers for inflammation. PCSK9 [57], SEMA3A [58] and SFRP4 [59] are associated with pain. PCSK9 [60], CNTN4 [61], SEMA3A [62], PTGIS (prostaglandin I2 synthase) [63], SFRP4 [64], MFAP5 [65], CDH6 [66], GPC6 [67] and PKP2 [68] might serve as genetic markers of ovarian cancer.…”
Section: Discussionmentioning
confidence: 99%
“…PCSK9 [48], CNTN4 [49], SEMA3A [50], SFRP4 [51], MFAP5 [52], BMP6 [53], CDH6 [54], PIEZO2 [55] and PKP2 [56] are a diagnostic markers for inflammation. PCSK9 [57], SEMA3A [58] and SFRP4 [59] are associated with pain. PCSK9 [60], CNTN4 [61], SEMA3A [62], PTGIS (prostaglandin I2 synthase) [63], SFRP4 [64], MFAP5 [65], CDH6 [66], GPC6 [67] and PKP2 [68] might serve as genetic markers of ovarian cancer.…”
Section: Discussionmentioning
confidence: 99%
“…The expression of inhibitory receptor CD94/NKG2A and NK cell expression was increased in patients with endometriosis. The presence of inhibitory phenotypic variants of NK cells in the ectopic endometrial tissue in adenomyosis has been equally reported, leading to the assumption that a lower cytotoxic potential of NK cells may facilitate the onset of adenomyosis/endometriosis [30][31][32]. In addition, in RIF patients the central disfunctions target the regulatory activity, expressed as altered angiogenic components (e.g., decreased VEGF and placental growth factor (PLGF)) [30].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, in RIF patients the central disfunctions target the regulatory activity, expressed as altered angiogenic components (e.g., decreased VEGF and placental growth factor (PLGF)) [30]. In terms of representativity, the results of a meta-analysis clearly showed that the uterine NK cell number did not differ significantly between patients with or without RIF [31], thus underlining the importance of both the numeric representation and the functionality of NK cells [32].…”
Section: Discussionmentioning
confidence: 99%
“…Specifically, keratinocytes were predominant in clusters #3, #5, #6, #7, #9, and #10, characterized by markers such as Epcam, Krt14, and Krt15 29 . Immune cells were distributed across clusters #0, #1, #2, #8, #11, #12, #13, #14, #15, #16, and #18, with specific markers identifying neutrophils (cluster #0, #1, and #2) 32 , monocyte-macrophage lineage (cluster #8) 33 , dendritic cells (clusters #11 and #15) 34 , plasmacytoid dendritic cells (cluster #12) 35 , T cells and natural killer cells (cluster #13) 36 , natural killer T cells (cluster #14) 37 , and mast cells (cluster #18) 38 . Cluster #19 remained undefined because specific markers were lacking (Fig.…”
Section: Scrna-seq Reveals Cell Heterogeneity Of Migrasome Injection ...mentioning
confidence: 99%